Showing results 4 to 4 of 4
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial Journal:European Journal of Preventive Cardiology | 2021 |